phase readout
saveNCT06247670: Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: CAMP4 Therapeutics Corporation. Phase: PHASE1. Conditions: Healthy Volunteers, OTC Deficiency
view source ↗
comments(0)
5-min edit window · permanent after that